BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 37325669)

  • 1. Ferroptosis-mediated immune responses in cancer.
    Qi D; Peng M
    Front Immunol; 2023; 14():1188365. PubMed ID: 37325669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Programmed Cell Death Tunes Tumor Immunity.
    Liu J; Hong M; Li Y; Chen D; Wu Y; Hu Y
    Front Immunol; 2022; 13():847345. PubMed ID: 35432318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ferroptosis and tumor immunity: In perspective of the major cell components in the tumor microenvironment.
    Zhu W; Liu X; Yang L; He Q; Huang D; Tan X
    Eur J Pharmacol; 2023 Dec; 961():176124. PubMed ID: 37925133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ferroptosis of immune cells in the tumor microenvironment.
    Kim R; Taylor D; Vonderheide RH; Gabrilovich DI
    Trends Pharmacol Sci; 2023 Aug; 44(8):542-552. PubMed ID: 37380530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research.
    Tong X; Tang R; Xiao M; Xu J; Wang W; Zhang B; Liu J; Yu X; Shi S
    J Hematol Oncol; 2022 Dec; 15(1):174. PubMed ID: 36482419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deciphering the potential roles of ferroptosis in regulating tumor immunity and tumor immunotherapy.
    Gu X; Liu Y; Dai X; Yang YG; Zhang X
    Front Immunol; 2023; 14():1137107. PubMed ID: 36926345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ferroptosis, a subtle talk between immune system and cancer cells: To be or not to be?
    Zhou Q; Tao C; Yuan J; Pan F; Wang R
    Biomed Pharmacother; 2023 Sep; 165():115251. PubMed ID: 37523985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Ferroptosis Molecular Subtype Reveals Characteristics of the Tumor Microenvironment, Immunotherapeutic Response, and Prognosis in Gastric Cancer.
    Xu X; Zhou N; Lan H; Yang F; Dong B; Zhang X
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association between ferroptosis-related patterns and tumor microenvironment in colorectal cancer.
    He C; Gu X; Dong C; Xu Z; Liu L; Jiang B; Lu Y; Jiang X; Lu Z
    Int Immunopharmacol; 2024 Jun; 134():112258. PubMed ID: 38744178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ferroptosis in the tumor microenvironment: perspectives for immunotherapy.
    Xu H; Ye D; Ren M; Zhang H; Bi F
    Trends Mol Med; 2021 Sep; 27(9):856-867. PubMed ID: 34312075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineered exosome-like nanovesicles suppress tumor growth by reprogramming tumor microenvironment and promoting tumor ferroptosis.
    Hu S; Ma J; Su C; Chen Y; Shu Y; Qi Z; Zhang B; Shi G; Zhang Y; Zhang Y; Huang A; Kuang Y; Cheng P
    Acta Biomater; 2021 Nov; 135():567-581. PubMed ID: 34506976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulating ferroptosis sensitivity: environmental and cellular targets within the tumor microenvironment.
    Hua Y; Yang S; Zhang Y; Li J; Wang M; Yeerkenbieke P; Liao Q; Liu Q
    J Exp Clin Cancer Res; 2024 Jan; 43(1):19. PubMed ID: 38217037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ferroptosis, as the most enriched programmed cell death process in glioma, induces immunosuppression and immunotherapy resistance.
    Liu T; Zhu C; Chen X; Guan G; Zou C; Shen S; Wu J; Wang Y; Lin Z; Chen L; Cheng P; Cheng W; Wu A
    Neuro Oncol; 2022 Jul; 24(7):1113-1125. PubMed ID: 35148413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammation-related pyroptosis, a novel programmed cell death pathway, and its crosstalk with immune therapy in cancer treatment.
    Hsu SK; Li CY; Lin IL; Syue WJ; Chen YF; Cheng KC; Teng YN; Lin YH; Yen CH; Chiu CC
    Theranostics; 2021; 11(18):8813-8835. PubMed ID: 34522213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptosis, Pyroptosis, and Ferroptosis Conspiringly Induce Immunosuppressive Hepatocellular Carcinoma Microenvironment and γδ T-Cell Imbalance.
    Hu Y; Chen D; Hong M; Liu J; Li Y; Hao J; Lu L; Yin Z; Wu Y
    Front Immunol; 2022; 13():845974. PubMed ID: 35444645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ferroptosis: Promising approach for cancer and cancer immunotherapy.
    Zheng S; Guan XY
    Cancer Lett; 2023 May; 561():216152. PubMed ID: 37023938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ferroptosis-associated molecular classification characterized by distinct tumor microenvironment profiles in colorectal cancer.
    Luo W; Dai W; Li Q; Mo S; Han L; Xiao X; Gu R; Xiang W; Ye L; Wang R; Xu Y; Cai S; Cai G
    Int J Biol Sci; 2022; 18(5):1773-1794. PubMed ID: 35342352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The roles of ferroptosis in cancer: Tumor suppression, tumor microenvironment, and therapeutic interventions.
    Lei G; Zhuang L; Gan B
    Cancer Cell; 2024 Apr; 42(4):513-534. PubMed ID: 38593779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ferroptosis in cancer: From molecular mechanisms to therapeutic strategies.
    Zhou Q; Meng Y; Li D; Yao L; Le J; Liu Y; Sun Y; Zeng F; Chen X; Deng G
    Signal Transduct Target Ther; 2024 Mar; 9(1):55. PubMed ID: 38453898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonferrous Ferroptosis Inducer Manganese Molybdate Nanoparticles to Enhance Tumor Immunotherapy.
    Lei H; Li Q; Pei Z; Liu L; Yang N; Cheng L
    Small; 2023 Nov; 19(45):e2303438. PubMed ID: 37420331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.